INTEGRAL AD SCIENCE HOLDING (IAS) Stock Analyst Ratings
USA - NASDAQ:IAS - US45828L1089 - Common Stock
10.28 USD
+0.01 (+0.1%)
10.28 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 54% to IAS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.8. This target is 14.82% above the current price.
IAS was analyzed by 20 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about IAS.
In the previous month the buy percentage consensus was at a similar level.
IAS was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | Stifel | Downgrade | Buy -> Hold |
| 2025-09-25 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-09-25 | Baird | Maintains | Neutral -> Neutral |
| 2025-08-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-22 | Stifel | Maintains | Buy -> Buy |
| 2025-05-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-05-05 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-23 | Stifel | Maintains | Buy -> Buy |
| 2025-04-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-28 | Baird | Downgrade | Outperform -> Neutral |
| 2025-03-03 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-03 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-05 | ScotiaBank | Initiate | Sector Perform |
| 2024-11-14 | Benchmark | Reiterate | Hold |
| 2024-11-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-13 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-13 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-05 | Benchmark | Reiterate | Hold |
| 2024-08-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-02 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-07-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-10 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-05-10 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-07 | Benchmark | Reiterate | Hold |
| 2024-04-30 | Loop Capital | Initiate | Buy |
INTEGRAL AD SCIENCE HOLDING / IAS FAQ
What do analysts expect the price target to be for INTEGRAL AD SCIENCE HOLDING (IAS)?
20 analysts have analysed IAS and the average price target is 11.8 USD. This implies a price increase of 14.82% is expected in the next year compared to the current price of 10.28.
What is the consensus rating for INTEGRAL AD SCIENCE HOLDING (IAS) stock?
The consensus rating for INTEGRAL AD SCIENCE HOLDING (IAS) is 54 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover INTEGRAL AD SCIENCE HOLDING (IAS) stock?
The number of analysts covering INTEGRAL AD SCIENCE HOLDING (IAS) is 20.